PlainRecalls
CriticalClass ITerminated

FDA Devices recall · Reported July 7, 2021

Lyra SARS-CoV-2 Assay (M120) in vitro diagnostic test reagent

In rare situations patients infected with high viral load of SARS CoV 2 may have samples that generate Ct values less than or equal to (d) 5 when certain amplification and detecti…

Recall #
Z-1928-2021
Affected scope
29,787 kits (96 results/kit)
Initiated
April 27, 2021
Verify with FDA Devices →
View my saved recalls

Quidel Corporation recalled Lyra SARS-CoV-2 Assay (M120) in vitro diagnostic test reagent - a critical-severity action.

Lyra SARS-CoV-2 Assay (M120) in vitro diagnostic test reagent was recalled by Quidel Corporation in July 7, 2021. Reason: In rare situations patients infected with high viral load of SARS CoV 2 may have samples that generate Ct val…. Check the official notice for the remedy. Verify recall #Z-1928-2021 with the FDA Devices before acting.

The recall

Quidel Corporation issued this critical-severity FDA Devices recall-In rare situations patients infected with high viral load of SARS CoV 2 may have samples that generate Ct val….

Critical
severity level
Class I
classification
July 7, 2021
reported

Sourced from official FDA Devices enforcement records. Verify recall #Z-1928-2021 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.

Recall Insight

This recall's affected scope, documented in the Recall Profile below, stays within a single-region or limited-distribution footprint. Distribution scope (see Distribution below) directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.

Within the same product category the archive holds 6 closely related recalls, 6 from FDA Devices - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.

Medical Devices recalls over time

Where this recall sits in its category - 41,021 medical devices recalls on record

01,0002,0003,0004,000 20052008201120142017202020232026 1,947
Severity1906864652High severity (most serious)Moderate severityLow severity
Where this agency-classified recall sits among FDA Class I/II/III notices

Of 88,244 recalls with an agency hazard classification, 19,068 are high severity, 64,652 moderate, and 4,524 low. A further 16,179 CPSC/NHTSA recalls have no agency class and are excluded from this split. This recall is classified high severity.

Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.

Product description

Lyra SARS-CoV-2 Assay (M120) in vitro diagnostic test reagent

Reason for recall

In rare situations patients infected with high viral load of SARS CoV 2 may have samples that generate Ct values less than or equal to (d) 5 when certain amplification and detection platforms (thermocyclers) are used. These specimens would be falsely interpreted as negative if target amplification occurs prior to a cycle threshold (Ct) value of 5. There have been no formal complaints of False Negative results with Ct values <5 from Lyra SARS-CoV-2 Assay users.

Recall Profile

Structured summary of the FDA Devices recall record
Attribute Value
Agency U.S. Food and Drug Administration
Severity class Critical (Class I)
Status Terminated
Recall number Z-1928-2021
Date reported July 7, 2021
Date initiated April 27, 2021
Recalling firm Quidel Corporation
Firm location Athens, OH
Affected scope 29,787 kits (96 results/kit)
Distribution Worldwide distribution - US Nationwide distribution in the states of AL, CA, CT, DC, FL, ID, IN, MA, MI, MO, NM, NY, OH, SC, TN, TX, WA and the countries of Canada, Saudi Arabia, United Kingdom.

Profile values are sourced directly from the official FDA Devices enforcement record. Source: U.S. Food and Drug Administration.

What to do with this recall

Match your product against the recall record, then act on the agency remedy.

  • Check the recall number (Z-1928-2021) and product description against the item you own. Search the archive
  • Confirm the current status with FDA Devices before acting, recall details can be updated.
  • This is a Class I (high-risk) recall, stop using the product immediately and follow the disposal or return instructions. What to do next

This page summarizes the official FDA Devices record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.

Frequently Asked Questions

What product was recalled?
Lyra SARS-CoV-2 Assay (M120) in vitro diagnostic test reagent. Recalled by Quidel Corporation. Units affected: 29,787 kits (96 results/kit).
Why was this product recalled?
In rare situations patients infected with high viral load of SARS CoV 2 may have samples that generate Ct values less than or equal to (d) 5 when certain amplification and detection platforms (thermocyclers) are used. These specimens would be falsely interpreted as negative if target amplification occurs prior to a cycle threshold (Ct) value of 5. There have been no formal complaints of False Negative results with Ct values <5 from Lyra SARS-CoV-2 Assay users.
Which agency issued this recall?
This recall was issued by the FDA Devices on July 7, 2021. Severity: Critical. Recall number: Z-1928-2021.
Where was the recalled product distributed?
Distribution: Worldwide distribution - US Nationwide distribution in the states of AL, CA, CT, DC, FL, ID, IN, MA, MI, MO, NM, NY, OH, SC, TN, TX, WA and the countries of Canada, Saudi Arabia, United Kingdom..
Should I stop using a recalled medication or medical device?
Do not stop using a recalled medication or device without consulting your healthcare provider first, as abruptly discontinuing treatment could pose its own health risks. Your doctor can advise on alternatives or whether the recall applies to your specific product lot. Check the recall number and lot information against your product packaging.

Nationwide recalls with similar severity or category timing

Drug and device notices outside this firm and state, matched by severity timing and product category.

Compare this recall with GORE VIABIL Short Wire Biliary Endoprosthesis, Model No. VS… → · All Medical Devices recalls

This recall: FDA Devices, reported July 7, 2021. Severity classes follow each agency's own taxonomy; related-recall context is computed across the full archive.

Methodology · Corrections · Archive as of August 2026